Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations

por Then Bergh, Florian, Kümpfel, Tania, Schumann, Erina, Held, Ulrike, Schwan, Michaela, Blazevic, Mirjana, Wismüller, Axel, Holsboer, Florian, Yassouridis, Alexander, Uhr, Manfred, Weber, Frank, Daumer, Martin, Trenkwalder, Claudia, Auer, Dorothee P
Publicado 2006